Karius Gains $100M and FDA Breakthrough Designation for Genomic Pneumonia Test
Karius Inc., a leading company in genomic diagnostics for infectious diseases, announced that its Karius Test has received the FDA's …
News
Sartorius and NVIDIA to Develop AI Models for Stem Cell-Derived Organoids, Reducing Animal Testing in Drug Discovery
Sartorius, a leader in life sciences and bioprocessing, is expanding its collaboration with NVIDIA to enhance the development of innovative …
Nabla Bio Advances Generative Protein Design with $26M Series A Funding
Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, …
Recursion Unveils BioHive-2, Fastest Pharma-Owned Supercomputer
Recursion Pharmaceuticals has achieved a significant milestone by completing BioHive-2, reportedly the fastest supercomputer to be wholly owned and operated …
Troubling Safety Data Overshadows Efficacy in MacroGenics' Phase 2 Study
MacroGenics, a biotechnology company, has reported concerning safety outcomes in its phase 2 trial of vobramitamab duocarmazine, a B7-H3-directed antibody-drug …
DeepMind Launches Advanced AlphaFold Model to Enhance Drug Discovery
Google DeepMind has introduced the latest version of its AlphaFold artificial intelligence model, which aims to assist scientists in designing …
Cytomos to Unveil Celledonia™ Technology at London Biotechnology Show 2024
Cytomos, a TechBio company, is gearing up to introduce attendees at the London Biotechnology Show 2024 to its latest development, …
Insilico Medicine Relocates Headquarters to Cambridge, Massachusetts
Insilico Medicine, a clinical-stage company specializing in AI-driven drug discovery, has shifted its corporate headquarters from New York to Boston. …
Xaira Therapeutics Launches with Over $1 Billion to Enhance Drug R&D Using AI
As first reported by Endpoints News, Xaira Therapeutics has emerged as one of the most significantly funded new entrants in …
Rubedo Garners $40M to Advance Clinical Trials in Age-Related Diseases
Rubedo Life Sciences, a biopharmaceutical company specializing in the development of therapies targeting senescent cells associated with age-related diseases, has …
Healthcare Industry Faces Cybersecurity Mismatch, According to Kroll's Latest Report
Kroll, a global leader in risk and financial advisory solutions, has unveiled findings from its recent "State of Cyber Defense: …
Isospec Analytics Secures $1.9 Million to Advance Biomolecular Identification Technology
Any given human blood sample has 15,000 small biological molecules that can give precise information about a person’s health at …